Selective Lobe Ventilation and a Novel Platform for Pulmonary Drug Delivery.

ABSTRACT: The current methods of mechanical ventilation and pulmonary drug delivery do not account for the heterogeneity of acute respiratory distress syndrome or its dependence on gravity. The severe lung disease caused by severe acute respiratory distress syndrome coronavirus 2, coronavirus disease 2019, is one of the many causes of acute respiratory distress syndrome. Severe acute respiratory distress syndrome coronavirus 2 has caused more than three million deaths worldwide and has challenged all therapeutic options for mechanical ventilation. Thus, new therapies are necessary to prevent deaths and long-term complications of severe lung diseases and prolonged mechanical ventilation. The authors of the present report have developed a novel device that allows selective lobe ventilation and selecti

SUBMITTER: Maracaja L 

PROVIDER: S-EPMC8095071 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature